ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Johnson, 84, died on Nov. 16, 2015, in Lititz, Pa.
“Alex had a 30-year career in chemical research at DuPont and DuPont-Merck Pharmaceuticals at the Experimental Station in Wilmington, Del. His research involved a broad series of projects on exploratory heterocyclic medicinal and plant growth regulatory efforts. He was the group manager of the cardiovascular research team that discovered Cozaar (losartan), the first of a new class of blood-pressure-regulating drugs. Alex was also the author or coauthor of 105 publications, held 14 patents and was the speaker at numerous scientific meetings. He was an emeritus member of the American Chemical Society and a fellow of the New Zealand Institute of Chemistry.”—Joan E. Johnson, wife
Most recent title: associate director of research, DuPont-Merck Pharmaceuticals
Education: B.Sc. and M.Sc., chemistry, 1953 and 1954, Victoria University of Wellington; Ph.D., chemistry, 1964, University of Rochester
Survivors: wife, Joan; daughters, Victoria and Alexandra; son, Christian; and five grandchildren
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter